[The bismuth-encephalopathy - a new pathological syndrome (author's transl)].
The publications concerning cases of bismuthencephalopathy seen in Australia, France, Switzerland and the Federal Republic of Germany are reported. The potential mechanisms of the development of this "new disease" are discussed.
D000284:Administration, Oral; D001729:Bismuth / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001812:Blood-Brain Barrier / Q000187:drug effects; D001927:Brain Diseases / Q000139:chemically induced*; D004569:Electroencephalography; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008134:Long-Term Care; D009207:Myoclonus / Q000139:chemically induced; D009824:Ointments / Q000009:adverse effects; D010859:Pigmentation Disorders / Q000188:drug therapy
D009824:Ointments; D001729:Bismuth
Die Wismutenzephalopathie - ein neuartiges Krankheitsbild?